Beacon Pharmaceuticals PLC has received an AA2 long-term rating and an ST-2 short-term rating from Credit Rating Agency of Bangladesh Limited, with a stable outlook.
The AA2 rating, the middle level within the AA category, indicates strong capacity to meet long-term financial obligations and relatively low credit risk. ST-2 reflects good capacity to meet short-term commitments on time.
The ratings were based on audited financial statements up to 30 June 2026, the company’s bank liability position as of 30 October 2026 and other relevant quantitative and qualitative information available at the declaration date.




